[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medipharm Labs Corp (MEDIF)

Medipharm Labs Corp (MEDIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0535 +5.23%
on 06/02/26
0.0755 -25.43%
on 05/14/26
-0.0096 (-14.57%)
since 05/01/26
3-Month
0.0426 +32.16%
on 03/31/26
0.0755 -25.43%
on 05/14/26
+0.0034 (+6.43%)
since 03/02/26
52-Week
0.0415 +35.66%
on 11/28/25
0.0755 -25.43%
on 05/14/26
-0.0019 (-3.26%)
since 06/02/25

Most Recent Stories

More News
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting

Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time). The Board of Directors recommends shareholders vote FOR all director nominees and resolutions,...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA

Q1 2026 Positive Adjusted EBITDA (1) Net Revenue of $9M with strong gross margins of 37% OPEX decreased 28% in Q1 2026 versus Q4 2025 Company is virtually debt free, with a Q1 ending cash balance of...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling

On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order rescheduling FDA-approved cannabis drug products and state-licensed medical cannabis from Schedule...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue

FY 2025 revenue of $45.1 million, an increase of 8% over 2024 International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenue Increased cash balance...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)
MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO

TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids,...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)
MediPharm Labs to Enter New Market with Costa Rica Supply Agreement

TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based...

MEDIF : 0.0563 (+1.26%)
LABS.TO : 0.0800 (+6.67%)

Key Turning Points

3rd Resistance Point 0.0619
2nd Resistance Point 0.0601
1st Resistance Point 0.0578
Last Price 0.0563
1st Support Level 0.0537
2nd Support Level 0.0519
3rd Support Level 0.0496

See More

52-Week High 0.0755
Fibonacci 61.8% 0.0625
Fibonacci 50% 0.0585
Last Price 0.0563
Fibonacci 38.2% 0.0545
52-Week Low 0.0415

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.